Claims for Patent: 4,604,463

Summary for Patent: 4,604,463

Title:	Camptothecin derivatives and process for preparing same
Abstract:	New camptothecin derivatives possessing high anti-tumor activity with slight toxicity, represented by the general formula: ##STR1## wherein R.sup.1 is a hydrogen atom, a halogen atom or an alkyl group with 1-4 carbon atoms and X is a chlorine atom or --NR.sup.2 R.sup.3 where R.sup.2 and R.sup.3 are the same or different and each represents a hydrogen atom, a substituted or unsubstituted alkyl group with 1-4 carbon atoms or a substituted or unsubstituted carbocyclic or heterocyclic group, with the proviso that when both R.sup.2 and R.sup.3 are the substituted or unsubstituted alkyl groups, they may be combined together with the nitrogen atom, to which they are bonded, to form a heterocyclic ring which may be interrupted with --O--, --S-- and/or >N--R.sup.4 in which R.sup.4 is a hydrogen atom, a substituted or unsubstituted alkyl group with 1-4 carbon atoms or a substituted or unsubstituted phenyl group and wherein the grouping --O--CO--X is bonded to a carbon atom located in any of the 9-, 10- and 11-positions in the ring A of camptothecin, as well as an ammonium salt or an alkali metal salt thereof. These new camptothecin derivatives are prepared by reacting a 7-R.sup.1 -camptothecin derivative having a hydroxyl group in any of the 9-, 10- and 11-positions on the ring A thereof with phosgen and then reacting, if necessary, the resultant 7-R.sup.1 -camptothecin derivative having a chlorocarbonyloxy group in the same position on the ring A thereof with an amine HNR.sup.2 R.sup.3 or by reacting a 7-R.sup.1 -camptothecin derivative having a hydroxyl group in any of the 9-, 10- and 11-positions on the ring A thereof with a carbamoyl chloride Cl-CONR.sup.2 R.sup.3.
Inventor(s):	Miyasaka; Tadashi (Kanagawa, JP), Sawada; Seigo (Tokyo, JP), Nokata; Kenichiro (Tokyo, JP), Sugino; Eiichi (Tokyo, JP), Mutai; Masahiko (Tokyo, JP)
Assignee:	Kabushiki Kaisha Yakult Honsha (Tokyo, JP)
Application Number:	06/627,980
Patent Claims:	1. Camptothecin derivatives of the formula: ##STR11## wherein R.sup.1 is a hydrogen atom, a halogen atom or an alkyl group with 1-4 carbon atoms and X is a chlorine atom or --NR.sup.2 R.sup.3 where R.sup.2 and R.sup.3 are the same or different and each represents a hydrogen atom, a substituted or unsubstituted alkyl group with 1-4 carbon atoms or a substituted or unsubstituted group selected from the group consisting of cyclopentyl, cyclohexyl, N-methylpiperidyl-(4), 2-pyrrolidyl, phenyl, tolyl, xylyl, pyridyl-2 and 2-methylpyridyl-(4), with the proviso that when both R.sup.2 and R.sup.3 are the substituted or unsubstituted alkyl groups, they may be combined together with the nitrogen atom, to which they are bonded, to form a heterocyclic ring selected from the group consisting of pyrrolidine, piperidine, 2-oxapyrrolidine, morpholine, thiomorpholine and 4-R.sup.4 piperizine rings in which R.sup.4 is a hydrogen atom, a substituted or unsubstitued alkyl group with 1-4 carbon atoms or a substituted or unsubstituted phenyl group and wherein the grouping --O--CO--X is bonded to a carbon atom located in any of the 9-, 10- and 11-positions in the ring A, and ammonium salts or alkali metal salts thereof. 2. The camptothecin derivatives according to claim 1, wherein R.sup.2, R.sup.3 or R.sup.4 in case of the alkyl group is substituted by one or more substituents selected from the following atoms and/or groups: ##STR12## wherein R.sup.5 is an alkyl group with 1-4 carbon atoms or a phenyl group which may be substituted by a halogen atom or an alkyl group with 1-4 carbon atoms, R.sup.6 is a hydrogen atom or an alkyl group with 1-4 carbon atoms, R.sup.7 is a hydrogen atom, a halogen atom, an alkyl group with 1-4 carbon atoms or an alkoxy group with 1-4 carbon atoms, n is an integer of 1-3, R.sup.8 and R.sup.9 are the same or different and each represents a hydrogen atom or an alkyl group with 1-4 carbon atoms with the proviso that when both R.sup.8 and R.sup.9 are the alkyl groups, they may be combined together with the nitrogen atom, to which they are bonded, to from a heterocyclic ring selected from the group consisting of pyrrolidine, piperidine, 2-oxapyrrolidine, morpholine and 4-R.sup.4 -piperazine rings, Q is the grouping --O--CO-- or --CO--O--, and A is a straight or branched chain alkylene group with 1-4 carbon atoms. 3. Camptothecin derivatives according to claim 1, which are 9-chlorocarbonyloxy-7-R.sup.1 -camptothecins. 4. Camptothecin derivatives according to claim 1, which are 10-chlorocarbonyloxy-7-R.sup.1 -camptothecins. 5. Camptothecin derivatives according to claim 1, which are 11-chlorocarbonyloxy-7-R.sup.1 camptothecins. 6. Camptothecin derivatives according to claim 1, which are 9-(4-R.sup.4 -1-piperazino)carbonyloxy-7-R.sup.1 -camptothecins. 7. Camptothecin derivatives according to claim 1, which are 9-(1-piperazino)carbonyloxy-7-R.sup.1 -camptothecins. 8. Camptothecin derivatives according to claim 1, which are 9-[(4-C.sub.1-4 alkylcarbamoylmethyl)-1-piperazino]carbonyloxy-7-R.sup.1 -camptothecins. 9. Camptothecin derivatives according to claim 1, which are 9-[4-(1-piperidino)-1-piperidino]carbonyloxy-7-R.sup.1 -camptothecins. 10. Camptothecin derivatives according to claim 1, which are 10-(di-C.sub.1-4 alkylamino)carbonyloxy-7-R.sup.1 -camptothecins. 11. Camptothecin derivatives according to claim 1, which are 10-[N-(di-C.sub.1-4 alkylamino-C.sub.1-4 alkyl)]aminocarbonyloxy-7-R.sup.1 -camptothecins. 12. Camptothecin derivatives according to claim 1, which are 10-[N-C.sub.1-4 alkyl-N-(di-C.sub.1-4 alkylamino-C.sub.1-4 alkyl)]aminocarbonyloxy-7-R.sup.1 -camptothecins. 13. Camptothecin derivatives according to claim 1, which are 10-[N-C.sub.1-4 alkyl-N-(1-C.sub.1-4 alkyl-4-piperidino)amino]carbonyloxy-7-R.sup.1 -camptothecins. 14. Camptothecin derivatives according to claim 1, which are 10-[4-R.sup.4 -1-piperazino]carbonyloxy-7-R.sup.1 -camptothecins. 15. Camptothecin derivatives according to claim 1, which are 10-(1-piperazino)carbonyloxy-7-R.sup.1 -camptothecins. 16. Camptothecin derivatives according to claim 1, which are 10-(4-C.sub.1-4 alkyl-1-piperazino)carbonyloxy-7-R.sup.1 -camptothecins. 17. Camptothecin derivatives according to claim 1, which are 10-(4-phenyl-1-piperazino)carbonyloxy-7-R.sup.1 -camptothecins. 18. Camptothecin derivatives according to claim 1, which are 10-(4-benzyl-1-piperazino)carbonyloxy-7-R.sup.1 -camptothecins. 19. Camptothecin derivatives according to claim 1, which are 10-[(4-C.sub.1-4 alkylcarbamoylmethyl)-1-piperazino]carbonyloxy-7-R.sup.1 -camptothecins. 20. Camptothecin derivatives according to claim 1, which are 10-[4-(piperidino)-1-piperidino]carbonloxy-7-R.sup.1 -camptothecins. 21. Camptothecin derivatives according to claim 1, which are 10-(4-morpholino)carbonyloxy-7-R.sup.1 -camptothecins. 22. Camptothecin derivatives according to claim 1, which are 11-(4-R.sup.4 -1-piperazino)carbonyloxy-7-R.sup.1 -camptothecins. 23. Camptothecin derivatives according to claim 1, which are 11-(4-C.sub.1-4 alkyl-1-piperazino)carbonyloxy-7-R.sup.1 -camptothecins. 24. Camptothecin derivatives according to claim 1, which are 11-[(4-C.sub.1-4 alkylcarbamoylmethyl)-1-piperazino]carbonyloxy-7-R.sup.1 -camptothecins. 25. Camptothecin derivatives according to claim 1, which are 11-[4-(1-piperidino)-1-piperidino]carbonyloxy-7-R.sup.1 -camptothecins.